- NPSP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $109.3 million.
- NPSP has traded 145,705 shares today.
- NPSP is down 3.7% today.
- NPSP was up 25.1% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in NPSP with the Ticky from Trade-Ideas. See the FREE profile for NPSP NOW at Trade-Ideas More details on NPSP: NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on parenteral support. NPSP has a PE ratio of 714.0. Currently there are 9 analysts that rate NPS Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for NPS Pharmaceuticals has been 1.6 million shares per day over the past 30 days. NPS has a market cap of $3.0 billion and is part of the health care sector and drugs industry. The stock has a beta of -0.38 and a short float of 12.5% with 1.97 days to cover. Shares are down 15.1% year-to-date as of the close of trading on Tuesday.